Topchoice Medical Stock Forecast for 2023 - 2025 - 2030
Updated on 05/01/2024
Topchoice Medical Stock Forecast and Price Target
If Topchoice Medical's stock price reached the average yearlong target of ¥71.00 given by two well-known analysts in recent months, there would be a potential upside of approximately 16.8% from its last closing price in May, 2024. This potential increase is based on a high estimate of ¥113.00 and a low estimate of ¥45.00. Even if you are not interested in 600763 stock, it is still crucial to be aware of its competitors.
16.80% Upside
Topchoice Medical Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Topchoice Medical's Price has decreased from ¥115.51 to ¥0.00 – a 100.00% drop! For next year, the 12 analysts predict Fair Value of ¥190.44, which would mean an increase of 100.00%. Over the next seven years, the pros' prediction is Fair Valueof ¥181.21, which would mean a seven-year growth forecast of 100.00%.
Topchoice Medical Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Topchoice Medical's Revenue has grown, increasing from ¥2.09B to ¥2.85B – an increase of 36.34%. For next year, the 12 analysts predict Revenue of ¥3.67B, which would mean an increase of 28.86%. Over the next seven years, the pros' prediction is Revenueof ¥7.74B, which would mean a seven-year growth forecast of 171.84%.
.jpg)
Topchoice Medical Dividend per Share Forecast for 2023 - 2025 - 2030
In the last zero years, Topchoice Medical has seen a decline in its Dividend per Share, from ¥0.44 to ¥0.44 – a 0.00% decrease. According to the 5 analysts polled, in the next year, Topchoice Medical's Dividend per Share will fall by 84.09%, reaching ¥0.07. By 2030, professionals believe that Topchoice Medical's Dividend per Share will have decreased by 100.00%, falling to ¥0.00.
Topchoice Medical EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Topchoice Medical's EBITDA has grown by 9.39%, from ¥712.61M to ¥779.52M. For the next year, analysts are expecting EBITDA to reach ¥1.23B – an increase of 57.39%. Over the next seven years, experts predict that EBITDA will grow by 51.26%.
Topchoice Medical EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Topchoice Medical's EBIT has grown from ¥650.34M to ¥694.85M – a 6.84% increase. Next year, analysts are expecting EBIT to reach ¥1.07B – an increase of 54.47%. Over the next seven years, the forecast is for EBIT to grow by 52.93%.
Topchoice Medical EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Topchoice Medical's EPS has decreased from ¥1.48 to ¥0.00 – a 100.00% drop! For next year, the 12 analysts predict EPS of ¥2.44, which would mean an increase of 100.00%. Over the next seven years, the pros' prediction is EPSof ¥2.32, which would mean a seven-year growth forecast of 100.00%.
.jpg)